Wolfspeed, Inc. (WOLF)
NYSE: WOLF · Real-Time Price · USD
1.510
+0.090 (6.34%)
Aug 7, 2025, 4:00 PM - Market closed
Sage Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts that cover Sage Therapeutics stock have a consensus rating of "Hold" and an average price target of $10.21, which forecasts a 576.16% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $20.
Price Target: $10.21 (+576.16%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sage Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 10 | 10 | 6 | 6 | 5 | 5 |
| Sell | 2 | 2 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 16 | 16 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Susquehanna | Susquehanna | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | -0.66% | Jul 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +297.35% | May 9, 2025 |
| Citigroup | Citigroup | Hold → Strong Sell Downgrades $7 → $3 | Hold → Strong Sell | Downgrades | $7 → $3 | +98.68% | May 9, 2025 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $15 → $8 | Strong Buy | Maintains | $15 → $8 | +429.80% | Apr 2, 2025 |
Financial Forecast
Revenue This Year
767.97M
from 807.20M
Decreased by -4.86%
Revenue Next Year
878.69M
from 767.97M
Increased by 14.42%
EPS This Year
-3.55
from -6.88
EPS Next Year
-2.62
from -3.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 794.9M | 1.1B | 1.1B |
| Avg | 768.0M | 878.7M | 1.0B |
| Low | 731.0M | 793.8M | 980.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.5% | 37.6% | 20.2% |
| Avg | -4.9% | 14.4% | 16.3% |
| Low | -9.4% | 3.4% | 11.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -3.38 | -2.01 | -0.79 | |
| Avg | -3.55 | -2.62 | -1.62 | |
| Low | -3.83 | -3.24 | -2.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.